Global Network to Provide More Scientists Access to Illumina's Sequencing Technology
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: 1 minute
Illumina, Inc. has announced the creation of the Illumina Genome Network, a global partnership designed to link researchers interested in conducting large-scale whole human genome sequencing projects with leading institutions that can perform such projects using Illumina sequencing.
The Genome Network will provide researchers who do not have access to high-quality, next-generation sequencing technology an economical and dependable way to complete their sequencing projects.
"With the rapidly increasing output of the Illumina HiSeq™ 2000, and the commensurate reduction in the price of sequencing genomes, more and more researchers are looking to advance their projects by leveraging this transformational technology," said Christian Henry, Senior Vice President and General Manager, Life Sciences. "By creating the Illumina Genome Network, we believe we can catalyze the development of the market for whole human genome sequencing and help the research community to accelerate the rate of research in human health and population genetics."
The Illumina Genome Network will include leading academic and commercial institutions worldwide that can rapidly process large-scale sequencing projects. Participating institutions must also have completed Illumina's Certified Service Provider (CSPro) certification. Illumina will serve as the channel to connect interested researchers with Network partners that will then perform the sequencing. The Network will focus on offering only whole genome human sequencing services for large scale projects.
GMI/Macrogen Inc. and the National Center for Genome Resources (NCGR) have already enrolled as partners in the Network. Illumina is in discussions with a number of other institutions about potentially joining the Network, among them the Broad Institute, BGI, University of Washington Department of Genome Sciences, and deCODE Genetics.
Illumina will begin offering whole human genome sequencing services through the Network immediately.
The Genome Network will provide researchers who do not have access to high-quality, next-generation sequencing technology an economical and dependable way to complete their sequencing projects.
"With the rapidly increasing output of the Illumina HiSeq™ 2000, and the commensurate reduction in the price of sequencing genomes, more and more researchers are looking to advance their projects by leveraging this transformational technology," said Christian Henry, Senior Vice President and General Manager, Life Sciences. "By creating the Illumina Genome Network, we believe we can catalyze the development of the market for whole human genome sequencing and help the research community to accelerate the rate of research in human health and population genetics."
The Illumina Genome Network will include leading academic and commercial institutions worldwide that can rapidly process large-scale sequencing projects. Participating institutions must also have completed Illumina's Certified Service Provider (CSPro) certification. Illumina will serve as the channel to connect interested researchers with Network partners that will then perform the sequencing. The Network will focus on offering only whole genome human sequencing services for large scale projects.
GMI/Macrogen Inc. and the National Center for Genome Resources (NCGR) have already enrolled as partners in the Network. Illumina is in discussions with a number of other institutions about potentially joining the Network, among them the Broad Institute, BGI, University of Washington Department of Genome Sciences, and deCODE Genetics.
Illumina will begin offering whole human genome sequencing services through the Network immediately.
